Transaction · 0001649245-26-000009

Febbo Phillip G.

Febbo Phillip G., CS, MO, reported a transaction classified as withholding at VERACYTE, INC. involving 3639.000000 shares for an estimated $163318.32. Reported holdings after the transaction were 146158.000000 shares. The stored filing text includes a detected 10b5-1 reference.

withholdingSEC transaction code FCS, MO
VCYTVERACYTE, INC.
Filing timeSep 04
Trade dateSep 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$42.53
Pre-filing
1mo ago +5.5%1w ago +4.1%1d ago +2.1%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

VCYT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
VCYT since 2026-09-04Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001649245-26-000009
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 04, 2026, 11:54 PM · 2d delay
Shares
3.63k sh
$4.48k per share
Estimated value
-$16.3M
Computed from shares × price
Holdings after
146k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-22score
Filing-only score

-22

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Scientific & Med Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does…

  2. F2

    The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.

  3. F3

    Represents weighted average sales price. Sale prices for the transactions range from $42.47 to $43.47. Detailed information regarding the number of shares sold at each separate price will be provided…

  4. F4

    Represents weighted average sales price. Sale prices for the transactions range from $43.475 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided…

Original filing · 0001649245-26-000009
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

VCYT